Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 221,472,000 papers from all fields of science
Search
Sign In
Create Free Account
AGN 193109
Known as:
AGN-193109
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Naphthalenes
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Independent pathways in the modulation of osteoclastic resorption by intermediates of the mevalonate biosynthetic pathway: the role of the retinoic acid receptor.
E. V. van Beek
,
C. Löwik
,
M. Karperien
,
S. Papapoulos
Bone
2006
Corpus ID: 34881171
2002
2002
Unique property of some synthetic retinoids: activation of the aryl hydrocarbon receptor pathway.
C. Gambone
,
Juliet M Hutcheson
,
+4 authors
D. Soprano
Molecular Pharmacology
2002
Corpus ID: 24141956
Potential pharmacological applications in the areas of oncology, dermatology, diabetes, and atherosclerosis of synthetic analogs…
Expand
2001
2001
The synthetic retinoid AGN 193109 but not retinoic acid elevates CYP1A1 levels in mouse embryos and Hepa-1c1c7 cells.
D. Soprano
,
C. Gambone
,
+4 authors
D. Kochhar
Toxicology and Applied Pharmacology
2001
Corpus ID: 40921775
The synthetic retinoid AGN 193109 is a potent pan retinoic acid receptor (RAR) antagonist. Treatment of pregnant mice with a…
Expand
1999
1999
Cell type and gene-specific activity of the retinoid inverse agonist AGN 193109: divergent effects from agonist at retinoic acid receptor gamma in human keratinocytes.
S. Thacher
,
S. Nagpal
,
+7 authors
R. Chandraratna
Cell growth & differentiation : the molecular…
1999
Corpus ID: 15623334
Retinoids are important regulators of epithelial differentiation. AGN 193109 is a high-affinity antagonist and inverse agonist…
Expand
1996
1996
Specific antagonist of retinoid toxicity in mice.
Andrew M. Standeven
,
Alan T. Johnson
,
M. Escobar
,
R. A. Chandraratna
Toxicology and Applied Pharmacology
1996
Corpus ID: 29428471
AGN 193109 was recently identified as a potent retinoic acid receptor (RAR) antagonist in vitro. The purpose of the present study…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE